Research and Markets, the largest resource for market research information in world providing essential market research reports, industry research, industry analysis, forecasts, market studies, company profiles and country reports.
Welcome - Home - Register - Login - Help/FAQ - 0 items View Basket
Worlds Largest Market Research Resource - 722206 Live Reports
Search Research and Markets
  Search
Enter keywords, a title or
a report id number below.





Advanced   
Company search
Register for free email updates of market research
Currency
  Select a currency for use throughout the site



Viewing report

Order by Fax
Printer Friendly
PDF Brochure
Send to Friend
Enquire before Buying
| More
Hard CopyAdd to Basket



Antitargets: Prediction and Prevention of Drug Side Effects
John Wiley and Sons Ltd, Jan 2008, Pages: 504


  Description  
  Table of Contents  
    
    
    
   
 Enquire before Buying  
 Send to a Friend  

This practice-oriented handbook surveys current knowledge on the prediction and prevention of adverse drug reactions related to off-target activity of small molecule drugs. It is unique in collating the current approaches into a single source, and includes several highly instructive case studies that may be used as guidelines on how to improve drug development projects.
With its large section on ADME-related effects, this is key knowledge for every drug developer.

Author Information

Roy Vaz is the head of investigative pharmacokinetics at the Bridgewater, NJ (USA) location of Sanofi-Aventis Pharmaceuticals. He received his Ph.D. in Organic Chemistry from the University of Florida, Gainesville (USA), after graduating from the Indian Institute of Technology in Mumbai (India). Prior to his present appointment, he has worked with Bristol-Myers-Squibb and Tripos. He is a specialist on the prediction and modeling of cytochrome-mediated drug metabolism.

Thomas Klabunde obtained his PhD in chemistry from the University of Münster (Germany). After a postdoctoral fellowship at the Texas A&M University, he was appointed Assistant Professor at the Institute for Bioscience and Technology in Houston (USA). Later on, he joined the pharmaceutical research of Sanofi-Aventis in Frankfurt (Germany), where he is currently a group leader. His main interest lies with drug design approaches for G protein-coupled receptors, notably in the areas of lead finding and chemogenomics.



Customers who bought this item also bought

hERG Screening

Adme/Tox Technologies

Nuclear Receptors in Drug Metabolism

Human Drug Metabolism: An Introduction

Drug Metabolism Handbook: Concepts and Applications

The Biochemistry of Drug Metabolism: Two Volume Set

Herg: Technology and Market Analysis

Drug Transporters and ADME: Pharmacological and Commercial Implications

Hit and Lead Profiling: Identification and Optimization of Drug-like Molecules

Repositioning ADME Studies: A Strategy to Reduce Drug Attrition

GPCR - Drug Targets

The Biochemistry of Drug Metabolism: Principles, Redox Reactions, Hydrolyses



Top of page


   All rights reserved. � Copyright 2009 Research and Markets
   Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster


Research and Markets RSS Feeds